Autism spectrum disorder (ASD) presents with a wide range of symptoms, but for those with severe autism, the challenges can be profound and life-altering. These individuals may struggle with minimal or absent speech, extreme sensory sensitivities, persistent anxiety, aggression or self-injury, and overwhelming difficulties with social connection and daily functioning. Families caring for these children often face immense stress and limited options for meaningful support. |
While no single gene causes autism, genetic susceptibility plays a foundational role in many cases. Functional medicine practitioners often evaluate single nucleotide polymorphisms (SNPs) that affect detoxification (such as GSTM1 and GSTT1), methylation (e.g., MTHFR, COMT), and neurotransmitter metabolism (e.g., MAO-A, SLC6A4). (1,2,3,4) These variations do not guarantee the development of autism but can reduce the body's resilience to environmental exposures or stressors. For example, children with impaired methylation pathways may struggle to regulate neurotransmitters or detoxify toxins, contributing to neurological inflammation and dysfunction. These inherited vulnerabilities make the individual more susceptible to external factors that could tip the balance toward neurodevelopmental disruption.
2. Environmental Triggers and Epigenetic Modifications
Environmental exposures during pregnancy and early childhood can significantly influence a child’s neurodevelopment, especially when combined with genetic predispositions. Toxins such as pesticides, heavy metals, endocrine-disrupting chemicals (like BPA), and air pollutants can alter gene expression through epigenetic mechanisms. Studies have linked prenatal exposure to air pollution and organophosphates with increased autism risk. (5,6) These environmental insults do not change DNA sequences but instead modify how genes are expressed, often at critical windows of brain development. Functional medicine approaches emphasize minimizing these exposures and enhancing the body’s ability to eliminate toxins, especially in sensitive populations.
3. Immune Dysregulation and Autoimmunity
A growing body of evidence links immune dysfunction and autoimmunity with autism. Children with ASD frequently present with signs of chronic inflammation, elevated pro-inflammatory cytokines (like IL-6 and TNF-alpha), and even autoantibodies against brain tissue or neural receptors. (7,8) Some mothers of children with autism have been found to carry specific maternal autoantibodies that cross the placenta and may interfere with fetal brain development. These immune disruptions can affect neural pruning, synaptic connectivity, and neurotransmission, all processes essential for proper cognitive and social function. In functional medicine, reducing inflammation and restoring immune balance are key therapeutic goals.
4. Mitochondrial Dysfunction
Mitochondria are the energy-producing organelles of the cell, and their dysfunction has been implicated in 30–50% of children with autism. These children can have impaired oxidative phosphorylation, increased lactate and pyruvate levels, and markers of mitochondrial stress on organic acid testing. (9/10) Clinically, mitochondrial dysfunction can present with fatigue, poor muscle tone, developmental regression after illness, and heightened sensitivity to environmental triggers. Because the brain requires high levels of energy for development and function, mitochondrial insufficiency can significantly impact cognitive and behavioral health. Functional medicine interventions typically include mitochondrial nutrients such as CoQ10, L-carnitine, B vitamins - especially thiamine (11), and antioxidants.
5. Oxidative Stress and Impaired Redox Regulation
Oxidative stress occurs when the production of reactive oxygen species exceeds the body's capacity to neutralize them. Children with autism often demonstrate low levels of key antioxidants, particularly glutathione, the master antioxidant responsible for detoxification and cellular repair. (12,13) This imbalance contributes to inflammation, immune dysregulation, and neuronal damage. Functional lab testing often reveals elevated markers of oxidative damage and low antioxidant reserves in children with ASD. Supporting redox balance with N-acetylcysteine, alpha-lipoic acid, and glutathione precursors has been shown to reduce symptoms such as irritability, repetitive behaviors, and mood instability.
6. Nutritional Deficiencies
Many children on the autism spectrum suffer from nutritional deficiencies due to limited diets, picky eating, digestive impairments, or increased metabolic demands. Commonly deficient nutrients include zinc, magnesium, iron, vitamin D, folate, B12, omega-3 fatty acids, and amino acids. (14,15) These nutrients are essential for neurotransmitter production, immune regulation, and mitochondrial function. Deficiencies can contribute to issues such as anxiety, poor focus, language delays, and hyperactivity. Functional medicine emphasizes individualized nutritional assessment and targeted repletion strategies to optimize brain function and support neurodevelopment.
7. Gut Dysbiosis and Gastrointestinal Inflammation
There is a well-established connection between gut health and brain health, often referred to as the gut-brain axis. Many children with autism experience gastrointestinal symptoms such as constipation, diarrhea, bloating, and food intolerances, symptoms that frequently correlate with behavioral changes. (16,17) Dysbiosis, or microbial imbalance, can lead to increased production of inflammatory metabolites and compromise the intestinal barrier ("leaky gut"). This allows immune-reactive substances to enter circulation and potentially impact brain function. Functional medicine practitioners use comprehensive stool testing, dietary changes, probiotics, and gut-healing protocols to rebalance the microbiome and improve both digestive and neurological symptoms.
8. Chronic Infections and Immune Activation
Chronic, low-grade infections are another important contributor to neuroinflammation and behavioral dysregulation in autism. Infections such as Lyme disease, Epstein-Barr virus, Mycoplasma pneumoniae, Candida, and Streptococcus (as in PANS/PANDAS) can trigger autoimmune responses that affect the central nervous system. (18,19) These infections may present with sudden regressions, OCD behaviors, anxiety, or motor tics. Functional medicine clinicians often investigate these infections through antibody panels, PCR testing, and clinical history. Treatment may involve herbal or pharmaceutical antimicrobials, immune-modulating therapies, and detoxification support to reduce pathogen load and restore neurological balance.
9. Impaired Detoxification
Detoxification pathways, especially those in the liver, play a crucial role in eliminating environmental toxins, metabolic byproducts, and inflammatory mediators. Many children with autism have reduced detox capacity due to genetic polymorphisms (e.g., in MTHFR or GST genes), low glutathione levels, or heavy toxic burden. (20, 21) Functional testing often reveals elevated levels of heavy metals, phthalates, or organic toxins in children with autism. These substances can accumulate and interfere with neurotransmitter signaling, mitochondrial function, and immune regulation. Functional medicine supports detoxification through gentle binding agents, targeted nutrients (such as B vitamins, glutathione, and magnesium), and lifestyle strategies that reduce exposure while enhancing natural elimination processes.
10. Vaccine Load, Aluminum Exposure, and Neurodevelopmental Vulnerability
In recent years, some researchers and clinicians have raised important questions about the potential contribution of the current vaccine schedule, particularly in children with preexisting vulnerabilities, to the development of neurodevelopmental disorders (NDDs), including autism. One peer-reviewed study titled “Vaccination and Neurodevelopmental Disorders: A Study of Nine-Year-Old Children Enrolled in Medicaid” found statistically significant associations between vaccination and increased odds of NDDs. (22) The authors concluded that “the current vaccination schedule may be contributing to multiple forms of NDD; that vaccination coupled with preterm birth was strongly associated with increased odds of NDDs compared to preterm birth in the absence of vaccination; and increasing numbers of visits that included vaccinations were associated with increased risks of ASD.” This research suggests that individual susceptibility, such as prematurity, mitochondrial dysfunction, or immune dysregulation, may influence how a child responds to multiple vaccine exposures.
In parallel, the work of Dr. Christopher Exley, a British aluminum toxicologist, has provided compelling evidence that aluminum, used as an adjuvant in many vaccines, can accumulate in the brains of individuals with autism. In his 2018 study published in Journal of Trace Elements in Medicine and Biology, Dr. Exley and colleagues found some of the highest aluminum concentrations ever measured in human brain tissue in samples from individuals with autism. (23) This raises concerns about whether children with certain detoxification challenges, such as impaired methylation or glutathione pathways, may be particularly vulnerable to aluminum retention.
Organizations such as Physicians for Informed Consent have also brought attention to the fact that the amount of aluminum administered through vaccines in early infancy can exceed the FDA’s safety limits for parenteral aluminum exposure, particularly in low-weight newborns. (24) For example, the cumulative aluminum content of the CDC’s recommended schedule for infants can surpass the limit considered safe for intravenous feeding solutions, without adequate research on how this aluminum is metabolized in developing infants with immature renal function. (25)
While vaccines play an important role in preventing infectious disease, these findings underscore the need for a more individualized and precautionary approach to vaccination, especially in children with known risk factors such as prematurity, chronic inflammation, mitochondrial issues, or family histories of autoimmunity or neurodevelopmental disorders. In functional medicine, this principle of bioindividuality, the recognition that one size does not fit all, is central to making safer, more informed healthcare decisions for children.
11. Folate Receptor Antibodies and Cerebral Folate Deficiency
A newly recognized yet critical root cause in a subset of children with autism is the presence of folate receptor alpha autoantibodies (FRAAs), which block the transport of folate across the blood-brain barrier. Discovered just over 20 years ago by Dr. Edward Quadros, these autoantibodies can lead to a condition known as cerebral folate deficiency (CFD), where folate levels in the central nervous system are low despite normal or elevated serum folate. (26) Folate is essential for neurotransmitter synthesis, DNA methylation, and myelination, and a deficiency in the brain can contribute to significant developmental challenges. Research by Dr. Edward Quadros, who originally discovered these antibodies, has shown that approximately 70% of children with autism test positive for FRAAs. (27) Functional medicine practitioners increasingly test for FRAAs and include folinic acid as a core intervention when appropriate, recognizing this as one of the most promising and reversible metabolic contributors to autism symptoms. in a subset of children with autism is the presence of folate receptor alpha autoantibodies (FRAAs), which block the transport of folate across the blood-brain barrier. This condition, known as cerebral folate deficiency (CFD), can lead to reduced central nervous system folate levels despite normal serum folate, impairing neurotransmitter synthesis, methylation, and myelination.
Building on Quadros' discovery, Dr. Vincent Ramaekers, Dr. Richard Frye, and Dr. Dan Rossignol have extensively studied the clinical application of high-dose folinic acid in children with autism who test positive for these autoantibodies. (28, 29) Clinical improvements reported include better expressive and receptive language, improved attention, reduced irritability, and gains in social engagement. In many cases, the improvements in speech, engagement, gross motor skills, and overall neurodevelopment have been profound. Functional medicine practitioners increasingly test for FRAAs and incorporate folinic acid supplementation into individualized treatment protocols, recognizing this as a reversible metabolic cause of autism symptoms in some children.
Autism is a complex, multifaceted condition that cannot be fully explained by genetics alone. As we continue to learn more about the biological underpinnings of neurodevelopmental disorders, it becomes increasingly clear that many children with autism are affected by identifiable, and often modifiable, underlying medical issues. From mitochondrial dysfunction and immune dysregulation to nutrient deficiencies, gut imbalances, and the presence of folate receptor antibodies, each of these root causes represents an opportunity for tailored interventions and meaningful improvement.
Functional medicine offers a personalized, systems-based approach that looks beyond the label of autism to uncover the unique biochemical and environmental factors affecting each child. By addressing these root causes, many clinicians, especially those trained through the Medical Academy of Pediatric Special Needs (MAPS), are witnessing children make remarkable gains in communication, learning, behavior, and overall quality of life.
At the same time, acceptance, awareness, and inclusion remain essential. Every child deserves to be seen, valued, and supported for who they are. But inclusion and advocacy should not come at the expense of medical investigation. Supporting optimal health and neurodevelopment can coexist with honoring each child's identity. In fact, helping children feel and function at their best is one of the most compassionate forms of acceptance we can offer.
- Mandic-Maravic V, Mitkovic-Voncina M, Pljesa-Ercegovac M, Savic-Radojevic A, Djordjevic M, Ercegovac M, Pekmezovic T, Simic T, Pejovic-Milovancevic M. Glutathione S-Transferase Polymorphisms and Clinical Characteristics in Autism Spectrum Disorders. Front Psychiatry. 2021 Jun 25;12:672389. doi: 10.3389/fpsyt.2021.672389.
- Owens B. Mercury, genes, and autism: A search for plausible associations. Environ Health Perspect. 2021;129(5):56002. doi:10.1289/EHP8660
- Pu D, Shen Y, Wu J. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: A meta-analysis. Autism Res. 2013;6(5):384-392. doi:10.1002/aur.1293
- Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet. 2005 Aug;77(2):265-79. doi: 10.1086/432648
- Lyall K, Schmidt RJ, Hertz-Picciotto I. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol. 2014;43(2):443-464. doi:10.1093/ije/dyt282
- Trasande L, Shaffer RM, Sathyanarayana S. Considering toxic chemicals in the etiology of autism. Pediatrics. 2022;149(1):e2021053012. doi:10.1542/peds.2021-053012
- Careaga M, Rogers S, Hansen RL, Amaral DG, Ashwood P. Immune endophenotypes in children with autism spectrum disorder. Biol Psychiatry. 2017;81(5):434-441. doi:10.1016/j.biopsych.2015.08.036
- Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25(1):40-45. doi:10.1016/j.bbi.2010.08.003
- Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis. Mol Psychiatry. 2012;17(3):290-314. doi:10.1038/mp.2010.136
- Frye RE. Biomarkers of mitochondrial dysfunction in autism spectrum disorder. Transl Psychiatry. 2020;10(1):232. doi: 10.1016/j.nbd.2024.106520
- Khanh vinh quốc Lương, Lan Thi Hoàng Nguyễn. The Role of Thiamine in Autism. American Journal of Psychiatry and Neuroscience. Vol. 1, No. 2, 2013, pp. 22-37. doi: 10.11648/j.ajpn.20130102.11
- Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006;13(3):171-181. doi:10.1016/j.pathophys.2006.05.007
- James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(8):947-956. doi:10.1002/ajmg.b.30366pmc.ncbi.nlm.nih.gov/articles/PMC4933016/
- Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8(1):34. doi:10.1186/1743-7075-8-34
- Wang T, Shan L, Du L, et al. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: A systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2016;25(4):341-350. doi:10.1007/s00787-015-0786-1
- Kang DW, Park JG, Ilhan ZE, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One. 2013;8(7):e68322. doi:10.1371/journal.pone.0068322
- Luna RA, Savidge TC, Williams KC. The brain-gut-microbiome axis: What role does it play in autism spectrum disorder? Curr Dev Disord Rep. 2017;4(1):59-69. doi: 10.1007/s40474-016-0077-7
- Swedo SE, Leckman JF, Rose NR. From research subgroup to clinical syndrome: Modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Therapeut. 2012;2(2):113. doi:10.4172/2161-0665.1000113
- Maltsev D, Solonko I, Sydorenko O. The assessment of microbial infection in children with autism spectrum disorders and genetic folate cycle deficiency. BMC Pediatr. 2024 Mar 21;24(1):200. doi: 10.1186/s12887-024-04687-1.
- Kern JK, Geier DA, Adams JB, et al. Toxicity biomarkers in autism spectrum disorder: A blinded study of urinary porphyrins. Pediatr Int. 2011;53(2):147-153. doi:10.1111/j.1442-200X.2010.03224.x
- Waring RH, Klovrza LV. Sulphur metabolism in autism. J Nutr Environ Med. 2000;10(1):25-32. doi.org/10.1080/13590840050000861
- Mawson AR, Ray BD, Bhuiyan AR, Jacob B. Vaccination and neurodevelopmental disorders: A study of 6- to 12-year-old children based on mother's medical records. J Transl Sci. 2017;3(3):1-15. doi:10.15761/JTS.1000186
- Exley C, Mold M, Shardlow E, Golub R. Aluminium in brain tissue in autism. J Trace Elem Med Biol. 2018;46:76-82. doi: 10.1016/j.jtemb.2017.11.012
- Physicians for Informed Consent. Aluminum in vaccines: What parents need to know. Physicians for Informed Consent Website. Published 2022. Accessed April 2025. https://physiciansforinformedconsent.org/aluminum
- Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO. Updated aluminum pharmacokinetics following infant exposures through diet and vaccination. Vaccine. 2011;29(51):9538-9543. doi:10.1016/j.vaccine.2011.09.124
- Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004;46(12):843-851. doi: 10.1017/s0012162204001471
- Quadros EV, Sequeira JM, Brown R, Jacobsen DW. Folate receptor autoimmunity and cerebral folate deficiency in autism spectrum disorders: a possible role of folinic acid as therapy. Dev Med Child Neurol. 2010;52(11):943-947. doi.org/10.3390/jpm11080710
- Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013;18(3):369-381. doi:10.1038/mp.2011.175
- Frye RE, Slattery J, Quadros EV, James SJ, Rossignol DA. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018;23(2):247-256. doi:10.1038/mp.2016.168